Kirill Kiselyov Selected Research

Mucolipidoses (Sialidosis)

1/2020	Early evidence of delayed oligodendrocyte maturation in the mouse model of mucolipidosis type IV.
1/2014	Loss of TRPML1 promotes production of reactive oxygen species: is oxidative damage a factor in mucolipidosis type IV?
3/2012	Loss of lysosomal ion channel transient receptor potential channel mucolipin-1 (TRPML1) leads to cathepsin B-dependent apoptosis.
9/2011	TRPML: transporters of metals in lysosomes essential for cell survival?
6/2008	Membrane traffic and turnover in TRP-ML1-deficient cells: a revised model for mucolipidosis type IV pathogenesis.
2/2007	TRPpathies.
12/2006	Mitochondrial aberrations in mucolipidosis Type IV.
3/2006	TRP-ML1 regulates lysosomal pH and acidic lysosomal lipid hydrolytic activity.
12/2005	TRP-ML1 is a lysosomal monovalent cation channel that undergoes proteolytic cleavage.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kirill Kiselyov Research Topics

Disease

9	Mucolipidoses (Sialidosis) 01/2020 - 12/2005
6	Lysosomal Storage Diseases (Lysosomal Storage Disease) 01/2014 - 03/2006
5	Neoplasms (Cancer) 01/2022 - 02/2007
3	Squamous Cell Carcinoma of Head and Neck 01/2022 - 12/2019
1	Iron Deficiencies 01/2020
1	Head and Neck Neoplasms (Head and Neck Cancer) 12/2019
1	Rupture 01/2018
1	Retinal Dystrophies 01/2018
1	Brain Contusion 01/2018
1	Pathologic Processes 01/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2015
1	Fabry Disease (Fabry's Disease) 02/2014
1	Parkinson Disease (Parkinson's Disease) 02/2013
1	Inborn Genetic Diseases (Disease, Hereditary) 07/2008
1	Dyspepsia (Indigestion) 07/2008
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 02/2007
1	Autosomal Dominant Polycystic Kidney (ADPKD) 02/2007
1	Channelopathies 02/2007
1	Cystic Fibrosis (Mucoviscidosis) 02/2007

Drug/Important Bio-Agent (IBA)

8	Ion Channels (Ion Channel)IBA 01/2014 - 12/2005
3	Proteins (Proteins, Gene)FDA Link 01/2016 - 07/2008
3	LipidsIBA 02/2014 - 12/2005
2	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2021 - 01/2014
2	Cisplatin (Platino)FDA LinkGeneric 11/2021 - 12/2019
1	RNA (Ribonucleic Acid)IBA 11/2021
1	IACS-010759IBA 11/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 11/2021
1	Ferritins (Ferritin)IBA 01/2020
1	IronIBA 01/2020
1	Transient Receptor Potential ChannelsIBA 01/2020
1	PlatinumIBA 12/2019
1	Carboplatin (JM8)FDA LinkGeneric 12/2019
1	Messenger RNA (mRNA)IBA 12/2019
1	CopperIBA 12/2019
1	CalciumIBA 01/2018
1	Adenosine Triphosphate (ATP)IBA 01/2018
1	ThapsigarginIBA 01/2018
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 01/2018
1	glycylphenylalanineIBA 01/2018
1	MetalsIBA 08/2015
1	EnzymesIBA 02/2014
1	GlycosphingolipidsIBA 02/2014
1	alpha-Galactosidase (Beano)IBA 02/2014
1	globotriaosylceramide (globotriosylceramide)IBA 02/2014
1	Neutral GlycosphingolipidsIBA 02/2014
1	Small Interfering RNA (siRNA)IBA 02/2014
1	CationsIBA 01/2014
1	A-factor (Streptomyces)IBA 01/2014
1	Lysergic Acid Diethylamide (LSD)IBA 01/2014
1	Leucine (L-Leucine)FDA Link 02/2013
1	Phosphotransferases (Kinase)IBA 02/2013
1	Annexin A5IBA 02/2010
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 02/2010
1	Cytochromes c (Cytochrome c)IBA 02/2010
1	Cyclin BIBA 02/2010
1	DNA (Deoxyribonucleic Acid)IBA 02/2010
1	disorazole C1IBA 02/2010
1	Vinblastine (Vinblastine Sulfate)FDA Link 02/2010
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2010
1	Macromolecular SubstancesIBA 07/2008
1	IonsIBA 02/2007
1	Biological ProductsIBA 02/2007
1	ElectrolytesIBA 02/2007
1	3-methyladenineIBA 12/2006
1	NigericinIBA 03/2006
1	Chloroquine (Aralen)FDA LinkGeneric 03/2006

Therapy/Procedure

2	Therapeutics 01/2022 - 11/2021
1	Drug Therapy (Chemotherapy) 01/2022